Enveric Biosciences Inc (NASDAQ:ENVB) has a beta value of 0.59 and has seen 2.57 million shares traded in the last trading session. The company, currently valued at $5.14M, closed the last trade at $0.50 per share which meant it gained $0.08 on the day or 19.50% during that session. The ENVB stock price is -484.0% off its 52-week high price of $2.92 and 40.0% above the 52-week low of $0.30. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.7 million shares traded. The 3-month trading volume is 634.72K shares.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Sporting 19.50% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ENVB stock price touched $0.50 or saw a rise of 6.54%. Year-to-date, Enveric Biosciences Inc shares have moved 40.88%, while the 5-day performance has seen it change 54.69%. Over the past 30 days, the shares of Enveric Biosciences Inc (NASDAQ:ENVB) have changed 50.40%. Short interest in the company has seen 0.33 million shares shorted with days to cover at 0.31.
Enveric Biosciences Inc (ENVB) estimates and forecasts
Figures show that Enveric Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 11.31% over the past 6 months, with this year growth rate of 74.03%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 71.22% over the past 5 years.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders own 6.93% of the company shares, while shares held by institutions stand at 7.06% with a share float percentage of 7.58%. Investors are also buoyed by the number of investors in a company, with Enveric Biosciences Inc having a total of 16.0 institutions that hold shares in the company. The top two institutional holders are ADVISORSHARES INVESTMENTS LLC with over 0.32 million shares worth more than $0.19 million. As of 2024-06-30, ADVISORSHARES INVESTMENTS LLC held 7.9233% of shares outstanding.
The other major institutional holder is GEODE CAPITAL MANAGEMENT, LLC, with the holding of over 44659.0 shares as of 2024-06-30. The firm’s total holdings are worth over $27688.0 and represent 1.1161% of shares outstanding.
